Arvinas ARVN
NASDAQ ARVN
$6.91 -0.01 (-0.14%)
At close: Nov 11, 2026 · 4:00 PM EST

Arvinas (ARVN) Gross Margin (2025 - 2026)

Updated

Analysis

Arvinas (ARVN) Gross Margin (2025 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 83.88%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 68.12%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 75.38%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 72.95%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 88.03%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 73.10%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 81.07%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 75.71%
10 Arvinas 453.26 Mn -1.97 Bn 400,000.00 80.00%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 80.00%
Jun 30, 2026 96.40%
Sep 30, 2025 100.00%
Jun 30, 2025 100.00%
API Access

Arvinas Gross Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-margin&ticker=ARVN&period=max&api_key=YOUR_API_KEY